Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 13, 2025 09:31 ET | Source: CMI

Vagus Nerve Stimulators Market to Hit USD 1,293.1 Million by 2032, at a CAGR of 9.9%, says Coherent Market Insights

Burlingame, CA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Vagus Nerve Stimulators Market is estimated to be valued at USD 667.4 Mn in 2025 and is expected to reach USD 1,293.1 Mn by 2032, exhibiting a...
November 12, 2025 07:00 ET | Source: Bexorg

Bexorg Strengthens Leadership Team with Appointment of Sean Murphy, Ph.D., as Chief Technology Officer

Bexorg strengthens leadership team with appointment of Sean Murphy, Ph.D., as Chief Technology Officer
November 06, 2025 09:00 ET | Source: Ozlo Sleep

Ozlo Announces Expansion of Medical Advisory Board to Guide Strategic Growth

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ozlo, the company behind the award-winning Ozlo Sleepbuds®, today announced the expansion of its Medical Advisory Board with the addition of two renowned...
October 13, 2025 17:41 ET | Source: KPC Health

Dr. Jeffrey Farkas Appointed Director of Neurosciences for KPC Health

KPC Health is pleased to announce the appointment of renowned neuroradiologist Dr. Jeffrey Farkas, MD, as Director of Neurosciences.
October 08, 2025 12:00 ET | Source: Unyte Health

Unyte Health Celebrates 10 Years as the Leader in Nervous System Regulation and Sound-Based Listening Therapies

Unyte Health marks 10 years as the leader of evidence-based listening therapies that support nervous system regulation, resilience, and mind-body wellness.
October 01, 2025 07:00 ET | Source: Aerska

Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain

Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain
September 24, 2025 08:18 ET | Source: Magstim EGI

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Monitoring for Neuroscience Research-New GES 500
September 24, 2025 01:30 ET | Source: Synendos Therapeutics AG

Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health

Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health
September 15, 2025 08:30 ET | Source: Actinogen Medical

Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease

SYDNEY, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces the successful conduct of its scheduled Type C meeting (written response) on Alzheimer’s disease (AD) with...
August 29, 2025 07:00 ET | Source: Arvinas Inc.

Arvinas to Participate in Upcoming Investor Conferences

NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...